Evermay Wealth Management LLC Eli Lilly & CO Transaction History

Evermay Wealth Management LLC

$661 Million
Q1 2024

A detailed history of Evermay Wealth Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Evermay Wealth Management LLC holds 4,183 shares of LLY stock, worth $3.59 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

4,183

Previous 4,288 2.45%

Holding current value

$3.59 Million

Previous $2.5 Million 30.21%

% of portfolio

0.49%

Previous 0.46%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $62,181 - $83,189	-105 Reduced 2.45%	4,183 $3.25 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $347,150 - $409,244	661 Added 18.22%	4,288 $2.5 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $31,733 - $43,748	73 Added 2.05%	3,627 $1.95 Million
Q2 2023 Aug 10, 2023	SELL	$350.74 - $468.98 $137,490 - $183,840	-392 Reduced 9.93%	3,554 $1.67 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $66,164 - $77,706	213 Added 5.71%	3,946 $1.36 Million

Q4 2022 Jan 19, 2023	BUY	$321.55 - $374.67 $57,879 - $67,440	180 Added 5.07%	3,733 $0
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $4,743 - $5,405	16 Added 0.45%	3,553 $1.15 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $119,853 - $140,726	430 Added 13.84%	3,537 $1.15 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $86,365 - $107,330	-368 Reduced 10.59%	3,107 $890,000
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $4,721 - $5,859	-21 Reduced 0.6%	3,475 $960,000
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $32,575 - $40,088	-147 Reduced 4.04%	3,496 $808,000
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $21,666 - $28,024	-120 Reduced 3.19%	3,643 $836,000
Q1 2021 May 10, 2021	SELL	$164.32 - $212.72 $4,108 - $5,318	-25 Reduced 0.66%	3,763 $703,000
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $25,048 - $33,144	192 Added 5.34%	3,788 $640,000
Q2 2020 Jul 20, 2020	SELL	$136.42 - $164.18 $40,925 - $49,254	-300 Reduced 7.7%	3,596 $590,000
Q1 2020 Apr 24, 2020	SELL	$119.05 - $147.35 $9,643 - $11,935	-81 Reduced 2.04%	3,896 $540,000
Q4 2019 Feb 11, 2020	BUY	$106.92 - $132.43 $98,794 - $122,365	924 Added 30.27%	3,977 $523,000
Q3 2019 Oct 29, 2019	SELL	$106.79 - $116.16 $2,883 - $3,136	-27 Reduced 0.88%	3,053 $341,000
Q2 2019 Jul 23, 2019	BUY	$110.79 - $129.32 $7,976 - $9,311	72 Added 2.39%	3,080 $341,000
Q1 2019 May 03, 2019	SELL	$111.31 - $131.02 $6,455 - $7,599	-58 Reduced 1.89%	3,008 $390,000
Q4 2018 Jan 24, 2019	BUY	$105.9 - $118.64 $118,184 - $132,402	1,116 Added 57.23%	3,066 $355,000
Q3 2018 Oct 29, 2018	BUY	$85.86 - $107.31 $167,427 - $209,254	1,950 New	1,950 $209,000

Others Institutions Holding LLY

# of Institutions

3,747

Shares Held

737M

Call Options Held

7.09M

Put Options Held

7.22M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $815B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Evermay Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evermay Wealth Management LLC with notifications on news.

Account

Evermay Wealth Management LLC Eli Lilly & CO Transaction History